Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
Open Access
- 27 September 2021
- journal article
- review article
- Published by MDPI AG in Epigenomes
- Vol. 5 (4), 20
- https://doi.org/10.3390/epigenomes5040020
Abstract
Pancreatic cancer is a molecularly heterogeneous disease. Epigenetic changes and epigenetic regulatory mechanisms underlie at least some of this heterogeneity and contribute to the evolution of aggressive tumor biology in patients and the tumor’s intrinsic resistance to therapy. Here we review our current understanding of epigenetic dysregulation in pancreatic cancer and how it is contributing to our efforts in early diagnosis, predictive and prognostic biomarker development and new therapeutic approaches in this deadly cancer.Keywords
This publication has 103 references indexed in Scilit:
- EZH2 couples pancreatic regeneration to neoplastic progressionGenes & Development, 2012
- Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic AdenocarcinomaClinical Cancer Research, 2011
- Increased methylation variation in epigenetic domains across cancer typesNature Genetics, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerThe New England Journal of Medicine, 2011
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic TransformationCancer Cell, 2010
- A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumoursBritish Journal of Cancer, 2010
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- CpG island methylation profile of pancreatic intraepithelial neoplasiaLaboratory Investigation, 2007
- Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylasesProceedings of the National Academy of Sciences of the United States of America, 2007
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000